A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate whether a new
compound, liraglutide, reduces the level of lipids (fat), including cholesterol, in the blood
of type 2 diabetics, following a meal with high fat content.